Title:
Genome Editing Market, By Technology (CRISPR/ Cas9, TALEN/Mega TALs, and ZFN), By Delivery method (Ex-vivo, In-vivo), By Application, By End Use, By Geography (NA, EU, APAC, and RoW) - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
REPORT HIGHLIGHT
The Genome Editing market was valued at USD 3.98 billion by 2017, growing with 10.68% CAGR during the forecast period, 2018-2025.
MARKET DYNAMICS
The study or practice of genome editing is one where genetic material is modified or manipulated within living organisms. This is done with the purpose of improving the quality of the organism. It is used in cases of crops and micro-organisms to improve the overall efficacy of the outcome or product that is expected. High-end technology is used to carry out highly sophisticated procedures such as this. Consistent technological advancement in this field will result in an escalation in the industry growth for genome editing. There is an increase in the funding by the government organizations for such R&D activities, thus acting as a catalyst to this growth. Advancement in technology such as the development of the CRISPR- Cas9 is a huge milestone in genome editing technology. The most significant market restraints include toxicity data associated with the activity of nucleases, besides this concerns addressed by animal rights activist and environmentalist over the ethics of genome editing is a rising concern.
TECHNOLOGY TAKEAWAY
Technologically the market is divided into CRISPR/ Cas9, TALEN/Mega TALs, ZFN, Others. CRISPR- Cas9 is one of the biggest and most revolutionary developments in the gene editing segment. It was taken in from a naturally occurring bacteria. The gene captures portion of DNA from an invading virus. These are also known as CRISPR arrays that help the gene remember the virus or sequence. This technology holds up to 45% of the market share in terms of revenue generation. Increase in R&D activities in vaccinations and drugs will boost this technology. Some of the others include TALEN/ Mega TAL's and ZFN. The Zinc finger nucleases will also experience significant growth in this category.
APPLICATION TAKEAWAY
Application wise this market is categorized as following, Cell Line Engineering/Gene Therapy, Animal Genetic Engineering, Plant Genetic Engineering, Other. Animal genetic engineering holds the most significant market share. A rise in dairy technology is a contributor to this industry. Following which the plant genetic engineering may be set to have a considerable increase in this segment.
DELIVERY METHODS TAKEAWAY
Two primary methods are used in order to carry out gene editing. These include ex vivo method and in vivo. Ex Vivo is the largest in terms of revenue generation. Ex vivo allows having better control over dosages being delivered to the cells.
END-USE TAKEAWAY
Based on end use the categorization is as follows Biotechnology & Pharmaceutical Industries, Academic & Government Research Institutes, Contract Research Organizations, Others. Pharmaceutical and biotechnological companies are spending a significant amount of time on R&D of various diseases and drug delivery and development. Research institutes own about one-third of the market chunk in terms of revenue.
REGION TAKEAWAY
U.S market will witness significant growth. The biggest contributing factor for this is the favourable regulatory scenario for this industry. India is also a booming market for an R&D standpoint. Growth in the number of initiatives that the government is taking to support this field makes it even more favourable in a developing country. India being an agriculturally driven country, there is tremendous scope and demand for crops that are genetically more productive and effective. Ongoing studies will help propel this industry in the right direction.
KEY VENDOR TAKEAWAY
Companies such Merck KGaA, CRISPR THERAPEUTICS, Cibus, Intellia Therapeutics, Inc., Recombinetics, Inc., Sangamo, AstraZeneca, Caribou Biosciences, Inc., Precision Biosciences, Editas Medicine Cellectis, Horizon Discovery Group, and Lonza are some of the market leaders with respect to the genetic editing.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year - 2014 & 2016
- Base Year - 2017
- Estimated Year - 2018
- Projected Year - 2025
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies and Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY TECHNOLOGY
- CRISPR/ Cas9
- ZFN
- TALEN/Mega TALs
- Others
MARKET, BY APPLICATION
- Cell Line Engineering/Gene Therapy
- Plant Genetic Engineering
- Animal Genetic Engineering
- Others
MARKET, BY DELIVERY MODE
MARKET, BY END USE
- Biotechnology & Pharmaceutical Industries
- Contract Research Organizations
- Government Research Institutes
- Others
MARKET, BY SERVICE
MARKET, BY REGION
- Europe
- Germany
- France
- Rest of Europe
- Rest of the World
- Middle East and Africa
- Latin America
TABLE OF CONTENT
1. GENOME EDITING MARKET OVERVIEW
- 1.1. Study Scope
- 1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
- 2.1. Market Snippet
- 2.1.1. Market Snippet by Technology
- 2.1.2. Market Snippet by Application
- 2.1.3. Market Snippet by Delivery Mode
- 2.1.4. Market Snippet by End Use
- 2.1.5. Market Snippet by Service
- 2.1.6. Market Snippet by Region
- 2.2. Competitive Insights
3. GENOME EDITING KEY MARKET TRENDS
- 3.1. Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Future Trends
4. GENOME EDITING INDUSTRY STUDY
- 4.1. Porter's Five Forces Analysis
- 4.2. Marketing Strategy Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. GENOME EDITING MARKET LANDSCAPE
- 5.1. Market Share Analysis
- 5.2. Key Innovators
- 5.3. Breakdown Data, by Key manufacturer
- 5.3.1. Established Player Analysis
- 5.3.2. Emerging Player Analysis
6. GENOME EDITING MARKET - BY TECHNOLOGY
- 6.1. Overview
- 6.1.1. Segment Share Analysis, By Technology, 2017 & 2025 (%)
- 6.2. CRISPR/ Cas9
- 6.2.1. Overview
- 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 6.3. ZFN
- 6.3.1. Overview
- 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 6.4. TALEN/Mega TALs
- 6.4.1. Overview
- 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 6.5. Others
- 6.5.1. Overview
- 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
7. GENOME EDITING MARKET - BY APPLICATION
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Application, 2017 & 2025 (%)
- 7.2. Cell Line Engineering/Gene Therapy
- 7.2.1. Overview
- 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 7.3. Plant Genetic Engineering
- 7.3.1. Overview
- 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 7.4. Animal Genetic Engineering
- 7.4.1. Overview
- 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 7.5. Others
- 7.5.1. Overview
- 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
8. GENOME EDITING MARKET - BY DELIVERY MODE
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Delivery Mode, 2017 & 2025 (%)
- 8.2. Ex-vivo
- 8.2.1. Overview
- 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 8.3. In-vivo
- 8.3.1. Overview
- 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
9. GENOME EDITING MARKET - BY END USE
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End Use, 2017 & 2025 (%)
- 9.2. Biotechnology & Pharmaceutical Industries
- 9.2.1. Overview
- 9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 9.3. Contract Research Organizations
- 9.3.1. Overview
- 9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 9.4. Government Research Institutes
- 9.4.1. Overview
- 9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 9.5. Others
- 9.5.1. Overview
- 9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
10. GENOME EDITING MARKET - BY SERVICE
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Service, 2017 & 2025 (%)
- 10.2. In-house
- 10.2.1. Overview
- 10.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 10.3. Contract
- 10.3.1. Overview
- 10.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
11. GENOME EDITING MARKET- BY GEOGRAPHY
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Region, 2017 & 2025 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Technology, 2014 - 2025 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Application, 2014 - 2025 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Delivery Mode, 2014 - 2025 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End Use, 2014 - 2025 (US$ Million)
- 11.2.8. North America Market Size and Forecast, By Service, 2014 - 2025 (US$ Million)
- 11.2.9. U.S.
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 11.2.10. Canada
- 11.2.10.1. Overview
- 11.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Technology, 2014 - 2025 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Application, 2014 - 2025 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Delivery Mode, 2014 - 2025 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End Use, 2014 - 2025 (US$ Million)
- 11.3.8. Europe Market Size and Forecast, By Service, 2014 - 2025 (US$ Million)
- 11.3.9. France
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 11.3.10. Germany
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 11.3.11. Rest of Europe
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Technology, 2014 - 2025 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2014 - 2025 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Delivery Mode, 2014 - 2025 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2014 - 2025 (US$ Million)
- 11.4.8. Asia Pacific Market Size and Forecast, By Service, 2014 - 2025 (US$ Million)
- 11.4.9. China
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 11.4.10. India
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 11.4.11. Rest of APAC
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 11.5. Rest of the World
- 11.5.1. Overview
- 11.5.2. Key Manufacturers in Rest of the World
- 11.5.3. Rest of the World Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
- 11.5.4. Rest of the World Market Size and Forecast, By Technology, 2014 - 2025 (US$ Million)
- 11.5.5. Rest of the World Market Size and Forecast, By Application, 2014 - 2025 (US$ Million)
- 11.5.6. Rest of the World Market Size and Forecast, By Delivery Mode, 2014 - 2025 (US$ Million)
- 11.5.7. Rest of the World Market Size and Forecast, By End Use, 2014 - 2025 (US$ Million)
- 11.5.8. Rest of the World Market Size and Forecast, By Service, 2014 - 2025 (US$ Million)
- 11.5.9. Latin America
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
- 11.5.10. Middle East and Africa
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
12. KEY VENDOR ANALYSIS
- 12.1. Merck KGaA
- 12.1.1. Company Snapshot
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Strategic Initiatives
- 12.2. CRISPR THERAPEUTICS
- 12.2.1. Company Snapshot
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Strategic Initiatives
- 12.3. Cibus
- 12.3.1. Company Snapshot
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Strategic Initiatives
- 12.4. Intellia Therapeutics, Inc.
- 12.4.1. Company Snapshot
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Strategic Initiatives
- 12.5. Recombinetics, Inc.
- 12.5.1. Company Snapshot
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Strategic Initiatives
- 12.6. Sangamo
- 12.6.1. Company Snapshot
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Strategic Initiatives
- 12.7. AstraZeneca
- 12.7.1. Company Snapshot
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Strategic Initiatives
- 12.8. Caribou Biosciences, Inc.
- 12.8.1. Company Snapshot
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Strategic Initiatives
- 12.9. Precision Biosciences
- 12.9.1. Company Snapshot
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Strategic Initiatives
- 12.10. Editas Medicine Cellectis
- 12.10.1. Company Snapshot
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Strategic Initiatives
- 12.11. Horizon Discovery Group
- 12.11.1. Company Snapshot
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Strategic Initiatives
- 12.12. Lonza
- 12.12.1. Company Snapshot
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Strategic Initiatives
13. 360 DEGREE ANALYSTVIEW
14. APPENDIX
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
比較リスト
